EUVIMEDEUVIMED entdecken
VergleichsstudieSystematische Übersicht

125I versus 103Pd brachytherapy for low risk prostate cancer: a systematic review

Lin-Lin Zhang, Li Ma, Jin-Hui Tian, Yao-Yao Ren, Ke-Hu Yang

Chinese Journal of Cancer · 2009

DOI: 10.5732/cjc.008.10378 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Chinese Journal of Cancer, 2009. Verfasst von Lin-Lin Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Evidence-based Medicine Center of Lanzhou University, School of Basic Medical Science, Lanzhou University, Lanzhou, Gansu, 73000, P.R.China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyDatabases, BibliographicDisease-Free SurvivalHumansIodine RadioisotopesMalePalladiumProstatic NeoplasmsRadiation InjuriesRadioisotopesRandomized Controlled Trials as TopicRectal DiseasesUrologic Diseases

Substanzen

Iodine RadioisotopesRadioisotopesPalladium

Autor:innen und Institutionen

  • Evidence-based Medicine Center of Lanzhou University, School of Basic Medical Science, Lanzhou University, Lanzhou, Gansu, 73000, P.R.China.

Zitieren

APA

Zhang, L. L., Ma, L., Tian, J. H., Ren, Y. Y., & Yang, K. H. (2009). 125I versus 103Pd brachytherapy for low risk prostate cancer: a systematic review. Chinese Journal of Cancer. https://doi.org/10.5732/cjc.008.10378

Vancouver

Zhang LL, Ma L, Tian JH, Ren YY, Yang KH. 125I versus 103Pd brachytherapy for low risk prostate cancer: a systematic review. Chinese Journal of Cancer. 2009. doi:10.5732/cjc.008.10378

BibTeX
@article{Zhang2009,
  author = {Zhang, Lin-Lin and Ma, Li and Tian, Jin-Hui and Ren, Yao-Yao and Yang, Ke-Hu},
  title = {125I versus 103Pd brachytherapy for low risk prostate cancer: a systematic review},
  journal = {Chinese Journal of Cancer},
  year = {2009},
  doi = {10.5732/cjc.008.10378}
}
Kostenlos starten →